Background: Aging microglia accumulate lipid droplets (LDs), secrete pro-inflammatory cytokines, and are defective in phagocytosis. The E4 allele of Apolipoprotein E (APOE) is the strongest genetic risk factor for late-onset Alzheimer's disease (LOAD) and is associated with increased neuroinflammation and LD accumulation. Here, we aimed to determine if the effects of aging and the E4 allele are synergistic in causing the accumulation of LDs seen in LOAD. Specifically, we hypothesize that APOE genotype modulates the LD proteome and lipidome at baseline and with inflammation. Additionally, we show the effects of APOE genotype and age on LD accumulation in monocyte-derived human macrophages treated with sex-matched exogenous serum.

Method: Primary microglia were isolated from mice expressing human ApoE3 and ApoE4. Microglia were exposed to oleic acid (OA), LPS, OA+LPS, dead N2A cells, or dead N2As+LPS to stimulate an inflammatory response, then lipid droplet content was analyzed. To examine the impact of inflammation on LDs in vivo, ApoE3 and ApoE4 mice were injected with saline or LPS and liver tissue collected at 24h. Density gradient centrifugation was used for isolation of LD-enriched fractions and these were analyzed using mass spectrometry proteomics. To determine the impact of age on circulating factors that may affect LD dynamics, human Peripheral Blood Mononuclear Cells (PBMCs) were treated with serum from different aged donors and the impact on LDs was analyzed.

Result: Primary microglia from ApoE4 mice accumulated significantly more LDs at baseline, with OA, LPS, and N2As as a percentage of E3 control. Proteomics revealed that LD fractions from E4 mice are enriched for proteins involved in innate immunity, while E3 LDs are enriched for lipid b-oxidation proteins. Lipidomics showed an increase in phosphatidylcholine distribution in the LD membrane of E4-control and LPS-treated droplets. Finally, a significant positive correlation between the age of serum samples used to treat human macrophages and LD accumulation in the PBMCs was observed.

Conclusion: In agreement with prior studies, E4 microglia accumulate more LDs compared to E3 microglia under all conditions tested. The proteomic profile of E4 LDs support the hypothesis that E4 expression increases inflammation under basal and stimulated conditions, causing a more robust response.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.091341DOI Listing

Publication Analysis

Top Keywords

microglia accumulate
8
lds
8
apoe genotype
8
human macrophages
8
primary microglia
8
apoe3 apoe4
8
apoe4 mice
8
microglia
6
basic science
4
science pathogenesis
4

Similar Publications

Alzheimer's disease (AD) is characterized by the accumulation of amyloid-β (Aβ) plaques and the aggregation of tau protein, resulting in intense memory loss and dementia. Diabetes-associated cognitive dysfunction (DACD) is a complication of diabetes mellitus, which is associated with decreased cognitive function and impaired memory. A growing body of literature emphasize the involvement of microglia in AD and DACD.

View Article and Find Full Text PDF

The switch from oxidative phosphorylation to glycolysis is crucial for microglial activation. Recent studies highlight that histone lactylation promotes macrophage homeostatic gene expression via transcriptional regulation, but its role in microglia activation in Parkinson's disease (PD) remains unclear. Here, we demonstrated that inhibiting glycolysis with 2-deoxy-D-glucose alleviates microgliosis, neuroinflammation and dopaminergic neurons damage by reducing lactate accumulation in PD mice.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) is the most common tauopathy and characterized by the progressive accumulation of Aß and tau. Tau is expressed in two major isoforms containing either 3 or 4 c-terminal repeats labeled as 3R and 4R tau. While these two isoforms occur in roughly equimolar ratios in AD, most research focus and mouse models of tau center only the 4Rtau protein and not 3Rtau.

View Article and Find Full Text PDF

Background: Clinicopathological studies of Alzheimer's disease (AD) have demonstrated that synaptic or neuronal loss and clinical cognitive decline do not reliably correlate with fibrillar amyloid burden. We created a transgenic mouse model overexpressing Dutch (E693Q) mutant human amyloid precursor protein (APP) driven by the pan-neuronal Thy1 promoter. Accumulation of APP carboxyl-terminal fragments was observed in the brains of these mice, which develop an impaired learning phenotype directly proportional to brain oAβ levels.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by hallmark pathologies that affect many brain regions, including the cellular microenvironment with the hippocampus, ultimately leading to profound deficits in cognition. Surprising recent work has shown that factors in the systemic environment regulate the hippocampal cellular niche; age-associated blood-borne factors exacerbate brain aging phenotypes, whereas youth-associated blood-borne factors, including tissue inhibitor of metalloproteinases 2 (TIMP2), reverse or ameliorate features of brain aging. As aging serves as the major risk factor for AD, and recent work shows that systemic factors can regulate AD pathology, we sought to characterize mechanisms by which the systemic environment regulates CNS phenotypes relevant to AD pathology through changes in neuroinflammation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!